<SEC-DOCUMENT>0001209191-23-017430-index.html : 20230308 <SEC-HEADER>0001209191-23-017430.hdr.sgml : 20230308 <ACCEPTANCE-DATETIME>20230308205447 ACCESSION NUMBER: 0001209191-23-017430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PURA VIDA INVESTMENTS, LLC CENTRAL INDEX KEY: 0001590144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 23717920 BUSINESS ADDRESS: STREET 1: 512 W 22ND STREET STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646-597-6995 MAIL ADDRESS: STREET 1: 512 W 22ND STREET STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kamen Efrem CENTRAL INDEX KEY: 0001789193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 23717919 MAIL ADDRESS: STREET 1: C/O PURA VIDA INVESTMENTS, LLC STREET 2: 512 W 22ND STREET, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncocyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20200213 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>doc4.xml <DESCRIPTION>FORM 4 SUBMISSION <TEXT> Document 1 - file: doc4.html
Document 1 - RAW XML: doc4.xml
</DOCUMENT> </SEC-DOCUMENT>